Premium
Use of serum CA‐125 in monitoring patients with uterine sarcoma: A preliminary report
Author(s) -
Patsner Bruce,
Mann William J.
Publication year - 1988
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19881001)62:7<1355::aid-cncr2820620719>3.0.co;2-4
Subject(s) - medicine , uterine sarcoma , laparotomy , sarcoma , chemotherapy , stage (stratigraphy) , gynecology , radiology , pathology , paleontology , biology
Elevated preoperative serum CA‐125 levels were present in three of four patients (75%) with Stage I uterine sarcoma found to have extrauterine spread of disease at laparotomy as well as five of seven (71%) patients with clinically advanced and recurrent uterine sarcoma. Serial levels during chemotherapy inconsistently reflected response to treatment and proved to have limited clinical value.